Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies

Sharing information with shareholders, Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said the company's strategy of developing the specialty business as an additional growth engine has started delivering results, with a gradual ramp up in specialty revenues.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2RZZ7Jl
via IFTTT